Corticosteroid Treatment in Chronic Rhinosinusitis: The Possibilities and the Limits

被引:79
作者
Mullol, Joaquim [1 ,2 ]
Obando, Andres [1 ]
Pujols, Laura [2 ]
Alobid, Isam [1 ]
机构
[1] Hosp Clin Barcelona, Dept Otorhinolaryngol, Unitat Rinol & Clin Olfacte, E-08036 Barcelona, Catalonia, Spain
[2] IDIBAPS, Barcelona 08036, Catalonia, Spain
关键词
Corticosteroids; Chronic rhinosinusitis; Nasal polyps; Endoscopic sinus surgery; Efficay and safety; AQUEOUS NASAL SPRAY; INTRANASAL FLUTICASONE PROPIONATE; GLUCOCORTICOID-RECEPTOR-ALPHA; PERENNIAL ALLERGIC RHINITIS; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; DOUBLE-BLIND; MOMETASONE FUROATE; GROWTH SUPPRESSION; BETA-ISOFORMS;
D O I
10.1016/j.iac.2009.07.001
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Chronic rhinosinusitis, including nasal polyps, is an inflammatory disease of the nose and sinuses. The medical treatment, mainly topical intranasal and oral corticosteroids, constitutes its first line of therapy. Long-term treatment with corticosteroid nasal spray reduces inflammation and nasal polyp size, and improves nasal symptoms such as nasal blockage, rhinorrea, and the loss of smell. Corticosteroid intranasal drops may be used when intranasal spray fails to demonstrate efficacy. Short courses of oral steroids are recommended in severe chronic rhinosinusitis with nasal polyps or when a rapid symptomatic improvement is needed. Endoscopic sinus surgery is only recommended when the medical treatment fails. Intranasal corticosteroids should be continued postoperatively. When using intranasal corticosteroids, care should be taken in selected populations such as children, pregnant women, and elderly patients; especially in those patients with comorbid conditions such as asthma, in which the overall steroid intake can be high due to the administration of both intranasal and inhaled corticosteroids.
引用
收藏
页码:657 / +
页数:14
相关论文
共 74 条
  • [1] Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide
    Agertoft, L
    Pedersen, S
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (05) : 948 - 952
  • [2] Al-Sayyad JJ, 2007, COCHRANE DB SYST REV, V24
  • [3] Allen DB, 2002, ALLERGY ASTHMA PROC, V23, P407
  • [4] Nasal polyposis and its impact on quality of life:: comparison between the effects of medical and surgical treatments
    Alobid, I
    Benítez, P
    Bernal-Sprekelsen, M
    Roca, J
    Alonso, J
    Picado, C
    Mullol, J
    [J]. ALLERGY, 2005, 60 (04) : 452 - 458
  • [5] [Anonymous], NIH Publication 20-MH-8125.
  • [6] Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery
    Aukema, AAC
    Mulder, PGH
    Fokkens, WJ
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (05) : 1017 - 1023
  • [7] Safety and tolerability of treatments for allergic rhinitis in children
    Baena-Cagnani, CE
    [J]. DRUG SAFETY, 2004, 27 (12) : 883 - 898
  • [8] Glucocorticoid resistance in inflammatory diseases
    Barnes, Peter J.
    Adcock, Ion M.
    [J]. LANCET, 2009, 373 (9678) : 1905 - 1917
  • [9] Steroid injection for sinonasal polyps: The University of Virginia experience
    Becker, Samuel S.
    Rasamny, J. K.
    Han, Joseph K.
    Patrie, James
    Gross, Charles W.
    [J]. AMERICAN JOURNAL OF RHINOLOGY, 2007, 21 (01): : 64 - 69
  • [10] A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps
    Benítez, P
    Alobid, I
    de Haro, J
    Berenguer, J
    Bernal-Sprekelsen, M
    Pujols, L
    Picado, C
    Mullol, J
    [J]. LARYNGOSCOPE, 2006, 116 (05) : 770 - 775